Omnes Capital

With roughly $7.8B under management, Omnes Capital ranks among the active investors in the AI space. That capital is deployed across their portfolio of AI-focused bets.

Across their portfolio, Omnes Capital has consistently backed companies in AI, Clean Tech, Health. These focus areas reflect where the firm sees the strongest risk-adjusted returns in AI.

Awaira currently tracks 1 companies in Omnes Capital's portfolio. The actual number may be higher, as some early-stage investments are not publicly disclosed.

The firm's sweet spot is Growth investing. That said, strong conviction deals can pull them into earlier or later rounds depending on the company.

The most notable deal on record for Omnes Capital is Omnes Capital is a growth-stage investment firm founded in 1999, headquartered in France, managing approximately $7.8B in assets under management. The firm concentrates on AI, Clean Tech, Health, deploying capital primarily at the growth level. Notable AI portfolio companies include Owkin. Omnes Capital has participated in 1 funding round tracked by Awaira, deploying capital across AI, Clean Tech, Health sectors. The firm's investment strategy emphasizes AI applications in healthcare and life sciences. Awaira assigns Omnes Capital an investor score of 58/100 based on portfolio strength, AI sector exposure, and market activity. The firm investment thesis centers on identifying AI companies that demonstrate strong technical moats, clear paths to revenue, and potential for category leadership within their respective segments. Omnes Capital evaluates opportunities based on team quality, market timing, technology differentiation, and capital efficiency. Portfolio companies including Owkin reflect the firm emphasis on backing founders who combine deep technical expertise with commercial execution capability.. It is the kind of investment that defines a fund's reputation in the AI ecosystem.